申请人:Ghosh Shomir
公开号:US20120214807A1
公开(公告)日:2012-08-23
The present invention provides compounds of general formula I:
or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R
1
are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
本发明提供了一般式I的化合物:或其药学上可接受的盐,其中X,n,Y和R1在此总体上和子集中被定义。本发明的化合物是CCR2的抑制剂,因此可用于治疗各种炎症、过敏和自身免疫性疾病、障碍或病况。